These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7705967)

  • 1. Selective killing of tumor cells in vitro by immunotoxin composed of antitumor antibiotic streptonigrin and polyclonal specific antibodies.
    Komissarenko SV; Penezina OP; Fomovskaya GN; Tolstikov VV; Preobrazhenskaya MN
    Int J Immunopharmacol; 1994 Dec; 16(12):1053-8. PubMed ID: 7705967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytotoxicity to hepatoma BEL-7402 cells of an antitumor monoclonal antibody-streptonigrin conjugate].
    Liu Y; Wu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Jun; 15(3):212-6. PubMed ID: 8222008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation and biological activities of monoclonal antibody-streptonigrin immunoconjugates].
    Liu YP; Wu JB
    Yao Xue Xue Bao; 1992; 27(7):498-502. PubMed ID: 1442081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of antitumor immunotoxins by liposomal monensin.
    Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
    J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
    Reiter Y; Pai LH; Brinkmann U; Wang QC; Pastan I
    Cancer Res; 1994 May; 54(10):2714-8. PubMed ID: 8168102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.
    Wu M; Tang SL; Zang RJ; Yu H
    Int J Immunopharmacol; 1990; 12(2):235-9. PubMed ID: 2329015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain.
    Fulton RJ; Uhr JW; Vitetta ES
    Cancer Res; 1988 May; 48(9):2626-31. PubMed ID: 3258547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cytotoxicity towards cytomegalovirus-infected cells by immunotoxins consisting of gelonin linked to anti-cytomegalovirus antibody.
    Barnett BB; Smee DF; Malek SM; Sidwell RW
    Antiviral Res; 1995 Sep; 28(1):93-100. PubMed ID: 8585763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological properties of streptonigrin derivatives. III. In vitro and in vivo antiviral and antitumor activities.
    Take Y; Kubo T; Takemori E; Inouye Y; Nakamura S; Nishimura T; Suzuki H; Yamaguchi H
    J Antibiot (Tokyo); 1989 Jun; 42(6):968-76. PubMed ID: 2737955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies].
    Tonevitskiĭ AG; Zhukova OS; Rakhmanova VA; Arsen'eva EL; Bogacheva GT
    Mol Biol (Mosk); 1988; 22(4):911-6. PubMed ID: 3141780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer.
    Weltman JK; Pedroso P; Johnson SA; Davignon D; Fast LD; Leone LA
    Cancer Res; 1987 Nov; 47(21):5552-6. PubMed ID: 2822229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv.
    Stish BJ; Chen H; Shu Y; Panoskaltsis-Mortari A; Vallera DA
    Clin Cancer Res; 2007 May; 13(10):3058-67. PubMed ID: 17505009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable pharmacodynamic features and superior anti-leukemic activity of B43 (anti-CD19) immunotoxins containing two pokeweed antiviral protein molecules covalently linked to each monoclonal antibody molecule.
    Myers DE; Yanishevski Y; Masson E; Irvin JD; Evans WE; Uckun FM
    Leuk Lymphoma; 1995 Jun; 18(1-2):93-102. PubMed ID: 8580835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N; Ueda M; Ozawa S; Abe O; Shimizu N
    Cancer Res; 1989 Dec; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth suppression of human colorectal carcinoma in nude mice by monoclonal antibody C27-abrin A chain conjugate.
    Tsai LC; Chen YL; Lee C; Chen HM; Chang ZN; Hung MW; Chao PL; Lin JY
    Dis Colon Rectum; 1995 Oct; 38(10):1067-74. PubMed ID: 7555421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
    Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
    Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T; Raso V
    Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human renal cancer by monoclonal-anti-body-linked methotrexate in an ascites tumor model.
    Singh M; Ghose T; Kralovec J; Blair AH; Belitsky P
    Cancer Immunol Immunother; 1991; 32(5):331-4. PubMed ID: 1998974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.